KVUE — Kenvue Inc.
—
NYSE ·
Materials ·
Chemicals ·
CIK 1944048 ·
Last close
$17.80
Market Cap
$34.19B
52W High
$19.67
52W Low
$13.22
ADV30
24,665,657
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 3,955,000,000 | 2,301,000,000 | 758,000,000 | 456,000,000 | 26,735,000,000 | 1,110,000,000 | 16,182,000,000 |
| Mar 2026 | 3,909,000,000 | 2,302,000,000 | 838,000,000 | 474,000,000 | 26,854,000,000 | 1,075,000,000 | 16,246,000,000 |
| Dec 2025 | 3,780,000,000 | 2,137,000,000 | 632,000,000 | 330,000,000 | 27,076,000,000 | 1,062,000,000 | 16,311,000,000 |
| Sep 2025 | 3,764,000,000 | 2,226,000,000 | 713,000,000 | 398,000,000 | 27,248,000,000 | 1,139,000,000 | 16,614,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,325,000,000
Investing CF
$-424,000,000
Financing CF
$-1,861,000,000
CapEx
$-411,000,000
Dividends Paid
$-1,592,000,000
Buybacks
$-70,000,000
EPS Diluted TTM
$0.87
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-70,000,000
Inventory
$1,722,000,000
Receivables
$2,926,000,000
ST Investments
—
EBIT TTM
$2,648,000,000
Pretax Income TTM
$2,223,000,000
Interest Exp TTM
$425,000,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,408,000,000
EBITDA
$3,480,999,936
Free Cash Flow
$1,907,500,032
Enterprise Value
$41,654,353,920
Total Cash
$1,110,000,000
Total Debt
$8,613,000,192
Shares Out
1,920,773,467
Trailing EPS
$0.85
Book Value
$5.50
ROE
15.6%
ROA
7.0%
Div Yield
4.72%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 15,124,000,000 | 2,715,000,000 | 1,470,000,000 | 27,076,000,000 | 16,311,000,000 | 10,765,000,000 | 2,197,000,000 |
| Dec 2024 | 15,455,000,000 | 2,629,000,000 | 1,030,000,000 | 25,601,000,000 | 15,933,000,000 | 9,668,000,000 | 1,769,000,000 |
| Dec 2023 | 15,444,000,000 | 2,493,000,000 | 1,664,000,000 | 27,851,000,000 | 16,640,000,000 | 11,211,000,000 | 3,168,000,000 |
| Dec 2022 | 14,950,000,000 | 2,688,000,000 | 2,064,000,000 | 27,316,000,000 | 7,346,000,000 | 19,970,000,000 | 2,525,000,000 |
TTM Snapshot
Revenues TTM
$15,344,000,000
NetIncome TTM
$1,729,000,000
OpCashFlow TTM
$0
Assets (Latest)
$27,076,000,000
Forward EPS
$1.24
Max Pain — expiry 2026-10-16
max pain strike: $18.00 · spot: $17.83 · call oi: 5,782 · put oi: 621
Expected Move to 2026-10-16:
±$0.70
(3.93%) —
implied range
$17.13 –
$18.53
· ATM straddle on $18.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NTR | Nutrien Ltd. | $34.47B | $72.23 | — |
| HLN | Haleon plc | $40.72B | $9.26 | — |
| PPG | PPG INDUSTRIES INC | $23.90B | $107.52 | — |
| EL | ESTEE LAUDER COMPANIES INC | $23.36B | $94.47 | — |
| CHD | CHURCH & DWIGHT CO INC /DE/ | $22.86B | $96.38 | — |
News headlines (Yahoo Finance, 1h cache)
Kenvue Inc's Dividend Analysis
2026-09-21 11:01 · Yahoo
Kimberly Clark (KMB) Lines Up Assets for $40 Billion Deal Review
2026-09-18 20:11 · Yahoo
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?
2026-09-18 03:50 · Yahoo
Should Kenvue’s (KVUE) TYLENOL with Naproxen Launch and Dividend Plan Prompt Investor Reassessment?
2026-09-15 17:12 · Yahoo
Is Kenvue (KVUE) A Bargain Following Its TYLENOL With Naproxen Launch?
2026-09-15 15:16 · Yahoo
Kimberly-Clark Moves to Clear EU Hurdle with Kenvue Asset Sales
2026-09-15 14:32 · Yahoo
Here's My Pick for the Smartest High-Yield Dividend Stock to Buy Right Now
2026-09-14 15:50 · Yahoo
Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand
2026-09-14 03:58 · Yahoo
Is Kenvue Underperforming the Nasdaq?
2026-09-12 17:57 · Yahoo
Kenvue Declares Quarterly Cash Dividend
2026-09-10 10:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.